Amyris, Inc. (3A01.F)

0,0391 0,0000 (0,00%) Börsenschluss: 10:50AM CEST

Amyris, Inc.

5885 Hollis Street
Suite 100
EmeryVille, CA 94608
United States
510 450 0761
https://amyris.com

Sektor(en): 
Branche: 
Vollzeitmitarbeiter: 1.598

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Hermanus Kieftenbeld	Interim CEO, CFO & Chief Administration Officer	601,67k	N/A	1966
Mr. Peter DeNardo	Senior Director of Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Doris Choi	General Counsel & Secretary	N/A	N/A	1978
Ms. Christine Ofori	Chief People Officer	N/A	N/A	N/A
Ms. Beth Baker Bannerman	Chief Engagement & Sustainability Officer	N/A	N/A	N/A
Ms. Daya Fields	President of Pipette & Purecane	N/A	N/A	N/A
Ms. Annie Tsong	Chief Product & Technology Strategy Officer	N/A	N/A	N/A
Mr. Philip J. Gund	Chief Restructuring Officer	N/A	N/A	N/A
Mr. Oreste Fieschi	President of Sweeteners & Ingredients	N/A	N/A	1958
Ms. Catherine Gore	President of Biossance	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Corporate Governance

Amyris, Inc.s ISS Governance QualityScore, Stand 29. April 2024, lautet 8. Die grundlegenden Scores sind Audit: 8, Vorstand: 4, Shareholderrechte: 8, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.